Heart and hypertension: The magnitude of the problem

Electrocardiographic and echocardiographic aspects
  • Edward D. Frohlich
  • Marc A. Pfeffer
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 98)


A close association has been demonstrated across many animal species between the mass of the heart and external work of the ventricle [1]. Thus, within any single species of animals, any prolonged augmentation in the hemodynamic overload imposed on the ventricle will result in hypertrophy of that chamber sustaining that load. Systemic arterial hypertension is the most common condition leading to left ventricular hypertrophy since it is this chamber which is the source for the augmented energy needed to overcome the chronic burden of the pressure overload.


Left Ventricular Hypertrophy Ventricular Hypertrophy Left Ventricular Mass Framingham Heart Study Hypertensive Population 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Holt JP, Rhode EA, Kines H (1968): Ventricular volumes and body weight in mammals. Am J Physiol 215: 705–715.Google Scholar
  2. 2.
    Pickering G (1982): Systemic arterial hypertension, in: Fishman AP, Richards DW (eds): Circulation of the Blood: Men and Ideas, pp 487–541. American Physiol Society.Google Scholar
  3. 3.
    Chanutin A, Barksdale EE (1933): Experimental renal insufficiency produced by partial nephrectomy. Arch Intern Med 52: 739–751.Google Scholar
  4. 4.
    Casale PN, Devereux RB, Alonso DR, Campo E, Kligfield P (1987): Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: Validation with autopsy findings. Circulation 75: 565–572.PubMedCrossRefGoogle Scholar
  5. 5.
    Reichek N, Devereux RB (1981): Left ventricular hypertrophy: Relationship of anatomic, echocardiographic and electrocardiographic findings. Circulation 63: 1391–1398.PubMedCrossRefGoogle Scholar
  6. 6.
    Frohlich ED (1986): Left ventricular hypertrophy as a risk factor, in: Messerli FH, Amodeo C (ed): Cardiology Clinics, Vol 4, pp 137–144. Philadelphia: W.B. Saunders.Google Scholar
  7. 7.
    Kannel WB, Dannenberg AL, Levy D (1987): Population implications of electrocardiographic left ventricular hypertrophy. Am J Cardiol 60: I 85–I 93.CrossRefGoogle Scholar
  8. 8.
    Kannel WB, Doyle JT, McNamara PM, Quickenton P, Gordon T (1975): Precursors of sudden coronary death: Factors related to the incidence of sudden death. Circulation 51: 606–613.PubMedGoogle Scholar
  9. 9.
    Messerli FH, Ventura HO, Elizardi DJ, Dunn FG, Fronlich ED (1984): Hypertension and sudden death: Increased ventricular ectopic activity in left ventricular hypertrophy. Am J Med 77: 18–22.PubMedCrossRefGoogle Scholar
  10. 10.
    McLenachan JM, Henderson E, Morris KI, Dargie HJ (1987): Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. New Engl J Med 311: 787–792.CrossRefGoogle Scholar
  11. 11.
    Veterans Administration Cooperative Study Group on Antihypertensive Agents (1967): Effects of treatment on morbidity in hypertension, I: Results in patients with diastolic blood pressures averaging 115 through 129 mmHg. JAMA 202: 116–1034.CrossRefGoogle Scholar
  12. 12.
    Veterans Administration Cooperative Study Group on Antihypertensive Agents (1970): Effects of treatment on morbidity in hypertension, II: Results in patients with diastolic pressure averaging 90 through 114 mmHg. JAMA 213: 1143–1152.CrossRefGoogle Scholar
  13. 13.
    Hypertension Detection and Follow-up Program Cooperative Group (1979): Five-year findings of the hypertension detection and follow-up program, I: Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 242: 2562–2571.CrossRefGoogle Scholar
  14. 14.
    Sokolow M, Perloff D (1961): The prognosis of essential hypertension treated conservatively. Circulation 23: 697–713.Google Scholar
  15. 15.
    Langford HG, Stamler J, Wassertheil-Smoller S, Prineas RJ (1986): All-cause mortality in the Hypertension Detection and Follow-up Program: Findings for the whole cohort and for persons with less severe hypertension, with and without other traits related to risk of mortality. Prog Cardiovasc Disease 29: 29–54.CrossRefGoogle Scholar
  16. 16.
    Kannel WB, Sorlie P (1981): Left ventricular hypertrophy in hypertension: prognostic and pathogenetic implications (the Framingham study), in: Strauer BE (ed): The Heart in Hypertension, pp 223–242. Berlin: Springer Verlag. (Boehringer-Mannheim Symposium Series).Google Scholar
  17. 17.
    Devereux RB, Casale PN, Wallerson DC, Kligfield P, Hammond IW, Liebson PR, Campo E, Alonso DR, Laragh JH (1987): Cost-effectiveness of echocardiography and electrocardiography for detection of left ventricular hypertrophy in patients with systemic hypertension. Hypertension 9(suppl II): II 69–II 76.Google Scholar
  18. 18.
    Devereux RB, Reichek N (1977): Echocardiographic determination of left ventricular mass in man: Anatomic validation of the method. Circulation 55: 613–618.PubMedGoogle Scholar
  19. 19.
    Levy D, Anderson KM, Savage DD, Kannel WB, Christiansen JC, Castelli WP (1988): Echocardiographically detected left ventricular hypertrophy: Prevalence and risk factors (The Framingham Heart Study). Ann Intern Med 108: 7–13.PubMedGoogle Scholar
  20. 20.
    Dunn FG, Chandraratna P, de Carvalho JGR, Basta LL, Frohlich ED (1977): Pathophysiologic assessment of hypertensive heart disease with echocardiography. Am J Cardiol 39: 789–795.PubMedCrossRefGoogle Scholar
  21. 21.
    Savage DD, Drayer JIM, Henry WL, Mathews EC, Ware JH, Gardin JM, Cohen ER, Epstein SE, Laragh JH (1979): Circulation 59: 623–632.PubMedGoogle Scholar
  22. 22.
    Hammond IW, Devereux RB, Alderman MH, Lutas EM, Spitzer MC, Crowley JS, Laragh JT (1986): The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. J Am Coll Cardiol 7: 639–650.PubMedCrossRefGoogle Scholar
  23. 23.
    Savage DD, Garrison RJ, Castelli WP, Kannel WB, Anderson SJ, Feinleib M (1985): Echocardiographic left ventricular hypertrophy in the general population is associated with increased 2-year mortality, independent of standard coronary risk factors (The Framingham Heart Study). AHA Council Cardiovasc Epidemiol Newsletter 37: 33.Google Scholar
  24. 24.
    Casale PN, Devereux RB, Milner M, Zullo G, Harshfield GA, Pickering TG, Laragh JH (1986): Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 105: 173–178.PubMedGoogle Scholar
  25. 25.
    Aronow WS, Epstein S, Schwartz KS, Koenigsberg M (1987): Correlation of complex ventricular arrhythmias detected by ambulatory electrocardiographic monitoring with echocardiographic left ventricular hypertrophy in persons older than 62 years in a long-term health care facility. Am J Cardiol 60: 730–732.PubMedCrossRefGoogle Scholar
  26. 26.
    Levy D, Anderson KM, Savage DD, Balkus SA, Kannel WB, Castelli WP (1987): Risk of ventricular arrhythmias in left ventricular hypertrophy (The Framingham Heart Study). Am J Cardiol 60: 560–565.PubMedCrossRefGoogle Scholar
  27. 27.
    Dunn FG, Pringle SD (1987): Left ventricular hypertrophy and myocardial ischemia in systemic hypertension. Am J Cardiol 60: I 19–I 22.CrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1989

Authors and Affiliations

  • Edward D. Frohlich
  • Marc A. Pfeffer

There are no affiliations available

Personalised recommendations